It will examine the
medicinals research and development process, from pre-clinical and
early-phase clinical development, to biomarker validation, study design
and management, data analysis, ethical review, regulatory submission
and research governance, using the field of rare pediatric rheumatic
disorders as a paradigm.
The conference is part of a Marie Curie Actions-sponsored series of
events entitled `Translational Research in Pediatric Rheumatology`
(TRiPR).
For more information, please visit:
http://www.sispge.com/tripr/